SEB Asset Management AB Purchases New Stake in Privia Health Group, Inc. $PRVA

SEB Asset Management AB acquired a new position in shares of Privia Health Group, Inc. (NASDAQ:PRVA) in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 24,528 shares of the company’s stock, valued at approximately $505,000.

Other large investors have also recently bought and sold shares of the company. Bayban bought a new position in Privia Health Group in the 4th quarter valued at about $26,000. Hantz Financial Services Inc. lifted its holdings in shares of Privia Health Group by 456.2% during the 4th quarter. Hantz Financial Services Inc. now owns 1,129 shares of the company’s stock worth $27,000 after acquiring an additional 926 shares during the period. Global Retirement Partners LLC lifted its holdings in shares of Privia Health Group by 579.8% during the 4th quarter. Global Retirement Partners LLC now owns 1,584 shares of the company’s stock worth $38,000 after acquiring an additional 1,351 shares during the period. Canada Pension Plan Investment Board lifted its holdings in shares of Privia Health Group by 48.0% during the 2nd quarter. Canada Pension Plan Investment Board now owns 3,700 shares of the company’s stock worth $85,000 after acquiring an additional 1,200 shares during the period. Finally, Kestra Advisory Services LLC acquired a new stake in shares of Privia Health Group during the 4th quarter worth approximately $93,000. 94.48% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of brokerages recently issued reports on PRVA. Barclays decreased their price objective on shares of Privia Health Group from $25.00 to $24.00 and set an “equal weight” rating on the stock in a research note on Tuesday, May 26th. Evercore set a $26.00 target price on Privia Health Group in a research note on Wednesday, April 8th. Weiss Ratings raised Privia Health Group from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, July 2nd. Citigroup reiterated a “buy” rating on shares of Privia Health Group in a research note on Thursday. Finally, Zacks Research cut Privia Health Group from a “hold” rating to a “strong sell” rating in a report on Tuesday, July 7th. Eleven research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, Privia Health Group presently has an average rating of “Moderate Buy” and a consensus price target of $31.15.

Insider Activity at Privia Health Group

In related news, Director Matthew Shawn Morris sold 88,110 shares of the stock in a transaction that occurred on Friday, June 26th. The shares were sold at an average price of $25.33, for a total value of $2,231,826.30. Following the completion of the transaction, the director owned 76,651 shares of the company’s stock, valued at $1,941,569.83. This represents a 53.48% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO David Mountcastle sold 24,734 shares of the firm’s stock in a transaction that occurred on Thursday, July 2nd. The shares were sold at an average price of $27.50, for a total transaction of $680,185.00. Following the completion of the sale, the chief financial officer owned 186,728 shares in the company, valued at $5,135,020. This represents a 11.70% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 478,855 shares of company stock valued at $12,099,109 in the last quarter. Insiders own 5.70% of the company’s stock.

Privia Health Group Trading Up 2.1%

PRVA opened at $25.50 on Friday. The company has a market cap of $3.21 billion, a P/E ratio of 159.38, a PEG ratio of 1.98 and a beta of 0.83. The company’s 50 day moving average is $24.40 and its 200-day moving average is $23.34. Privia Health Group, Inc. has a 1-year low of $18.77 and a 1-year high of $28.82.

About Privia Health Group

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.